| Clinical Investigator (CI) |
Yes |
Yes |
IVR, NPIVR
(for DCP studies) |
Yes |
Yes |
1 |
1 |
No |
System |
Investigator at the site responsible for signing the DTL for a given protocol and with overall responsibility for the study conduct at the site. |
| DTL Administrator (DTLA) |
Yes |
Yes |
IVR, NPIVR, AP |
Yes |
Yes |
1 |
3 |
No |
System |
Person assigned by the CI to manage the DTL. |
| Authorized User Prescribing |
No |
No |
IVR |
No
No roster requirement at the enrolling site, but person must be claimed at a TRF Provider that is linked to the enrolling site |
Yes |
1 |
NA |
No |
System, Audit |
Investigator at the site responsible for writing a patient order for a CTEP IND radiopharmaceutical as a licensed Authorized User for the radioisotope in a licensed facility for the radioisotope. |
| Authorized User Drug Mailing |
No |
No |
IVR, NPIVR, AP |
No
No roster requirement at the enrolling site, but person must be claimed at a TRF Provider that is linked to the enrolling site |
Yes |
2 |
NA |
No |
System, Audit |
Individual at the site responsible for receiving, storing, and dispensing a CTEP IND radiopharmaceutical as a licensed, trained, or qualified Authorized User or handler for the radioisotope in a licensed facility for the radioisotope. |
| Authorized User for Medical Use |
No |
No |
IVR, NPIVR, AP |
No
No roster requirement at the enrolling site, but person must be claimed at a TRF Provider that is linked to the enrolling site |
Yes |
NA |
NA |
No |
System, Audit |
Individual at the site licensed as an Authorized User for medical use of the radioisotope in a licensed facility for the radioisotope for a CTEP IND radiopharmaceutical. |
| Consenting Person |
No |
Yes |
IVR, NPIVR, AP |
Yes |
Yes |
1 |
NA |
No |
System, Audit |
Person listed in OPEN as having responsibility for consent. |
| Eligibility Assessments |
No |
Yes |
IVR, NPIVR |
Yes |
Yes |
1 |
NA |
No |
Audit |
Individual responsible for verification of eligibility. |
| End Point Assessment |
No |
Yes |
IVR, NPIVR |
Yes |
Yes |
1 |
NA |
No |
Audit |
Individual responsible for assessing study end points. |
| Enrolling Person/Treating Investigator |
No |
Yes |
IVR, NPIVR
(for DCP studies) |
Yes |
Yes |
1 |
NA |
No |
System |
Investigator listed in OPEN as having responsibility for subject treatment (aka, Enrolling Investigator). |
| History and Physical (H&P) Assessments |
No |
Yes |
IVR, NPIVR |
Yes |
No |
1 |
NA |
No |
Audit |
Individual responsible for conducting physical exams and assessments. |
| IND Prescribing |
No |
Yes |
IVR, NPIVR |
Yes |
Yes |
NA |
NA |
No |
Audit |
Individual responsible for writing patient treatment orders for IND agents. |
| Investigational Product Accountability |
No |
Yes |
IVR, NPIVR, AP, A |
No |
No |
1 |
NA |
No |
Audit |
Individual responsible for tracking receipt, distribution, dispensing, and final disposition of study-provided agents. |
| OPEN Registrar |
No |
Yes |
IVR, NPIVR, AP |
Yes |
No |
1 |
NA |
Registrar |
System |
Provides OPEN registration write access to the individual responsible for enrolling patients in OPEN. |
| Pathology Lab Support |
No |
No |
IVR, NPIVR, AP, A |
No |
No |
NA |
NA |
No |
Audit |
Pathology lab support. |
| Patient Screening/Recruiting |
No |
No |
IVR, NPIVR, AP |
Yes |
No |
NA |
NA |
No |
Audit |
Responsible for screening and recruiting subjects. |
| Primary Study/Site Contact |
No |
No |
IVR, NPIVR, AP |
Yes |
No |
NA |
NA |
No |
Audit |
The point of contact for the study. |
| Rave CRA |
No |
Yes |
IVR, NPIVR, AP |
Yes |
No |
1 |
NA |
Rave CRA |
System |
Provides Rave write access to the individuals responsible for data management activities within Rave. |
| Rave Investigator |
No |
No |
IVR, NPIVR |
Yes |
Yes |
NA |
NA |
Site Investigator |
System |
Investigator assigned to sign off on the CRFs in Rave. |
| Regulatory Contact |
No |
No |
IVR, NPIVR, AP |
No |
No |
NA |
NA |
No |
Audit |
Site staff responsible for regulatory submissions and maintaining essential documents. |
| RT/Imaging Support |
No |
No |
IVR, NPIVR, AP, A |
No |
No |
NA |
NA |
No |
Audit |
RT/imaging support (primarily TRIAD-related, but could be other). |
| Source Documentation Completion |
No |
No |
IVR, NPIVR, AP |
Yes |
No |
NA |
NA |
No |
Audit |
Responsible for collecting data on study-related assessments. |
| Study-Related Interventions |
No |
No |
IVR, NPIVR, AP, A |
No |
No |
NA |
NA |
No |
Audit |
Responsible for coordinating and/or administering study-related interventions and procedures. |
| Toxicity Assessment |
No |
Yes |
IVR, NPIVR |
Yes |
Yes |
1 |
NA |
No |
Audit |
Responsible for assessing adverse events. |
| Unblinded Study Personnel |
No |
No |
IVR, NPIVR, AP |
Yes |
Yes |
2 |
NA |
No |
System |
Study personnel responsible for handling, preparing, and labeling study agents to ensure blinded study randomization is protected at the site. Must have a signed Pharmacy Agreement on file. At a minimum, one of the listed personnel must be the Shipping Designee at the drug shipment site. |